瘤免疫微环境的变化与人体内导管内皮质粘膜瘤的进展相关
Kevin T Jamouss1, Alexander Ioannis Damanakis1, Abigail C Cornwell1
1Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
The Journal of pathology
|February 26, 2025
概括
早期的胰腺癌干预需要了解前体病变,如导管内皮质粘膜瘤 (IPMN). 这项研究揭示了高等级IPMN中向免疫抑制瘤微环境 (TME) 的转变,表明了癌症拦截的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 胰腺管道腺癌 (PDAC) 往往是晚诊断的.
- 早期干预前体病变,如导管内 papillary 粘膜瘤 (IPMN) 是至关重要的,但需要区分低风险和高风险的病变.
- 了解IPMN进展期间瘤微环境 (TME) 变化是防止过度治疗的关键.
研究的目的:
- 在进展到高度发育不良时,对IPMNs的TME变化进行表征.
- 为了识别与IPMN进展相关的免疫细胞变化和分子标记.
- 探索IPMN中TME变化的临床相关性.
主要方法:
- 免疫组织化学被用来量化免疫细胞密度和激活状态.
- 对100多个人类IPMN样本进行了分析.
- 用一个独立的队列来评估VISTA表达和临床结果之间的关联.
主要成果:
- 高级IPMN与低级IPMN相比,表现出更具免疫抑制性的TME.
- 在高等级的IPMN中观察到免疫检查点分子 (PD-L1,TIM3,VISTA) 的表达升高,巨细胞的增加和细胞毒性T细胞的减少.
- 在IPMN患者中,VISTA表达与较差的临床结果相关.
结论:
- IPMN的进展与TME的显著变化有关,促进了免疫抑制状态.
- 免疫检查点分子和特定的免疫细胞群 (巨细胞,T细胞) 是IPMN进展的关键参与者.
- 针对TME,特别是VISTA,可能为早期胰腺癌拦截提供新的策略.
关键词:
癌症免疫学 癌症免疫学免疫检查点是一个检查点.免疫逃避 免疫逃避免疫抑制的微环境导管内 papillary 粘膜性瘤的发生.淋巴细胞的透透.胰腺管道腺癌瘤瘤异质性的异质性瘤免疫微环境是一个微环境.瘤进展的进展情况更多相关视频
09:32Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
Published on: February 8, 2018
14.5K
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
7.4K
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
